|
1
|
Berkenblit A and Cannistra SA: Advances in
the management of epithelial ovarian cancer. J Reprod Med.
50:426–438. 2005.PubMed/NCBI
|
|
2
|
Radisky DC: Epithelial-mesenchymal
transition. Cell Sci. 118:4325–4326. 2005. View Article : Google Scholar
|
|
3
|
Batlle E, Sancho E, Francí C, et al: The
transcription factor snall is a repressor of E-cadherin gene
expression in epithelial tumour cells. Nat Cell Biol. 2:84–89.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cano A, Pérez-Moreno MA, Rodrigo I, et al:
The transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thiery JP: Epithelial mesenchymal
transition in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Imai T, Horiuchi A, Wang C, et al: Hypoxia
attenuates the expression of E-cadherin via up-regulation of SNAIL
in ovarian carcinoma cells. Am J Pathol. 163:1437–1447. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dohadwala M, Yang SC, Luo J, et al:
Cyclooxygenase-2-dependent regulation of E-cadherin: Prostaglandin
E (2) induces transcriptional repressors ZEB1 and snail in
non-small cell lung cancer. Cancer Res. 66:5338–5345. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar :
|
|
10
|
Luo D, Wang J, Li J and Post M: Mouse
snail is a target gene for HIF. Mol Cancer Res. 9:234–245. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Blechschmidt K, Sassen S, Schmalfeldt B,
et al: The E-cadherin repressor Snail is associated with lower
overall survival of ovarian cancer patients. Br J Cancer.
98:489–495. 2008. View Article : Google Scholar
|
|
12
|
Siegal GP, Wang MH, Rinehart CA Jr, et al:
Development of a novel human extracellular matrix for quantitation
of the invasiveness of human cells. Cancer Lett. 69:123–132. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan H, Ye K, Wang Z and Tang H:
Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2
expression in differentiated thyroid carcinoma. Jpn J Clin Oncol.
38:528–533. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Katoh M and Katoh M: Pharmacogenomics on
gastric cancer. Cancer Biol Ther. 3:566–567. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bachtiary B, Schindl M, Pötter R, et al:
Overexpression of hypoxia-inducible factor 1 alpha indicates
diminished response to radiotherapy and unfavorable prognosis in
patients receiving radical radiotherapy for cervical cancer. Clin
Cancer Res. 9:2234–2240. 2003.PubMed/NCBI
|
|
16
|
Jiang YA, Fan LF, Jiang CQ, et al:
Expression and significance of PTEN, hypoxia-inducible factor-1
alpha in colorectal adenoma and adenocarcinoma. World J
Gastroenterol. 9:491–494. 2003.PubMed/NCBI
|
|
17
|
Nakayama K, Kanzaki A, Hata K, et al:
Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in
human ovarian carcinoma. Cancer Lett. 176:215–223. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang BH, Agani F, Passaniti A and
Semenza: V-SRC induces expression of hypoxia-inducible factor 1
(HIF-1) and transcription of genes encoding vascular endothelial
growth factor and enolase l: Involvement of HIF-1 in tumor
progression. Cancer Res. 57:5328–5335. 1997.PubMed/NCBI
|
|
19
|
Yang MH, Wu MZ, Chiou SH, et al: Direct
regulation of TWIST by HIF-1 alpha promotes metastasis. Nat Cell
Biol. 10:295–305. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kurrey NK, K A and Bapat SA: Snail and
Slug are major determinants of ovarian cancer invasiveness at the
transcription level. Gynecol Oncol. 97:155–165. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
De Craene B and Berx G: Snail in the frame
of malignant tumor recurrence. Breast Cancer Res. 8:1052006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Olmeda D, Moreno-Bueno G, Flores JM, et
al: SNAI1 is required for tumor growth and lymph node metastasis of
human breast carcinoma MDA-MB-231 cells. Cancer Res.
67:11721–11731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoshida J, Horiuchi A, Kikuchi N, et al:
Changes in the expression of E-cadherin repressors, Snail, Slug,
SIP1 and Twist, in the development and progression of ovarian
carcinoma: The important role of Snail in ovarian tumorigenesis and
progression. Med Mol Morphol. 42:82–91. 2009. View Article : Google Scholar : PubMed/NCBI
|
